Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

UCL Business describes new CRP inhibitors

Sep. 17, 2021

Bahcesehir Universitesi presents Hdm2 inhibitors

Sep. 17, 2021

KRAS just wants to help: Pancreatic KRAS mutations may be protection gone bad

Sep. 17, 2021

Bayer gives details on discovery of IRAK-4 inhibitors BAY-845 and BAY-839

Sep. 16, 2021

Nurix Therapeutics and Gilead Sciences describe new PROTACs

Sep. 16, 2021

Medshine Discovery synthesizes new RET inhibitors

Sep. 16, 2021

New potent and selective USP7 inhibitor S-205474 presented

Sep. 16, 2021

Vipergen and PhoreMost enter into multitarget drug discovery agreement

Sep. 15, 2021

Theseus Pharmaceuticals divulges EGFR mutant inhibitors

Sep. 15, 2021

eIF4A3 identified as possible therapeutic target for cancer

Sep. 15, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...